Panther Life Sciences announced its strategic alliance with Pitt BioForge.
This partnership seeks to advance the production of Panther’s Microarray Patch (MAP) platform, accelerating and scaling manufacturing innovations to deliver thermostable, direct-to-consumer, data-centric treatments for a wide range of ailments.
Panther Life Sciences is commercializing licensed technology developed at the University of Pittsburgh and Carnegie Mellon University. This technology established foundational scientific know-how for skin biology and MAP technology, enabling Panther to develop a pipeline of skin-based treatments for therapeutic applications. Microarray Patches (MAPs) consists of an array of microscopic projections that can penetrate the upper layers of the skin and deliver a wide variety of compounds.
Panther’s project at BioForge is focused on accelerating scaled manufacturing of MAPs. Central to the Panther-BioForge project is the development and demonstration of an improved, automated manufacturing line designed to:
- Reduce labor costs through cutting-edge automation.
- Enhance production scalability.
- Deliver cost-effective solutions to meet global healthcare demands
